Red Herring, the venture capital magazine, has a piece on a company called Theranos, founded and being run by Elizabeth Holmes. The company has been developing a device which detects adverse drug reactions. It works by analyzing a tiny amount of blood from a person’s finger or arm, then transmitting the data to a Theranos server, which uses biostatistics algorithms to profile the information. In 2004, there were more than 400,000 adverse drug reactions reported to the FDA, and Ms Holmes wants this device to bring the numbers down. She also believes that the device could fundamentally change healthcare by determining of a particular drug is working on an individual basis.
She just turned 21 — and this is her second company. Theranos has funding from Draper Fisher Jurvetson, among others.
|100 people you must follow on twitter in 2014|
|How the heck does the stock exchange work, anyway?|
|This Video Will Make You Wish You Were an Entrepreneur in the 1980s|
|The Chinese Train That Never Stops|
|Even the Shopping Cart Needed Marketing|
|Entrepreneurs Take Too Many Showers|
|Science is Cool, Even the Science of Christmas Trees|
|3D Print Your Unborn Baby|
|How to Attract Better Clients|
|The Economics of North Dakota’s Oil Boom|